Chemoinformaics analysis of trans-Dihydroagarofuran
| Molecular Weight | 222.372 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
| Exact Molecular Weight | 222.198 | nRing | 3 |
| Solubility: LogS | -4.551 | nHRing | 1 |
| Solubility: LogP | 4.577 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 0 | BPOL | 27.8194 |
| QED | 0.598 |
| Synth | 5.396 |
| Natural Product Likeliness | 3.082 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.061 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.607 |
| MDCK | 0.000018 |
| BBB | 0.475 |
| PPB | 0.974173 |
| VDSS | 1.938 |
| FU | 0.027597 |
| CYP1A2-inh | 0.086 |
| CYP1A2-sub | 0.669 |
| CYP2c19-inh | 0.254 |
| CYP2c19-sub | 0.947 |
| CYP2c9-inh | 0.275 |
| CYP2c9-sub | 0.475 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.824 |
| CYP3a4-inh | 0.225 |
| CYP3a4-sub | 0.473 |
| CL | 10.598 |
| T12 | 0.108 |
| hERG | 0.023 |
| Ames | 0.019 |
| ROA | 0.033 |
| SkinSen | 0.13 |
| Carcinogencity | 0.205 |
| EI | 0.552 |
| Respiratory | 0.949 |
| NR-Aromatase | 0.32 |
| Antiviral | Yes |
| Prediction | 0.861937 |